Skip to the swatches
Pets

Sample No. 0016

FIP Testing: How MF-ICC Can Help Build a More Confident Diagnosis

Cats Castillo, Therese

MF-ICC can add useful evidence when feline infectious peritonitis is suspected, but vets still need to weigh test results against samples and clinical signs.

FIP Testing: How MF-ICC Can Help Build a More Confident Diagnosis
A grey cat laying down a fleece blanket, seemingly low on energy.
Bigstock

For cats with suspected feline infectious peritonitis (FIP), a new diagnostic approach may help clinicians assemble stronger evidence without relying on a surgical biopsy. Multiplex fluorescent immunocytochemistry (MF-ICC) looks for feline coronavirus antigen inside macrophages, the cells associated with FIP. A study found it performed well among the tests assessed, but it cannot confirm or exclude the disease on its own.

That distinction matters now that antiviral treatment is available. An uncertain diagnosis can delay care for a cat with FIP, while treating a cat that has another illness can prolong the search for the real cause of its signs. Samantha J.M. Evans, DVM, PhD, DACVP, DACVM, associate professor of clinical pathology at Colorado State University (CSU) and lead author of the study, describes FIP as particularly difficult to identify in its non-effusive form. In her view, clinicians need to combine the patient’s presentation with multiple diagnostic findings.

Why the target cell matters

Feline coronavirus is common, especially where many cats live together. Most cats exposed to it do not develop FIP. As a result, detecting the virus or an immune response to it does not necessarily show that a cat has the systemic disease.

Common diagnostic tools provide different kinds of evidence. Reverse transcription polymerase chain reaction (RT-PCR) detects viral RNA, while serology measures antibodies to coronavirus. The serum albumin-to-globulin ratio can add support when blood chemistry changes fit the clinical picture. Histopathology combined with immunohistochemistry can establish a diagnosis, but collecting tissue may require an invasive procedure—an added concern for an unstable patient.

MF-ICC aims to connect evidence of the virus with the cell in which it appears. Fluorescent antibodies mark feline coronavirus antigen and vimentin, a cellular marker used to identify macrophages. The resulting images are taken at different wavelengths and overlaid to check whether both markers appear within the same cell.

Finding coronavirus alone may reflect the common intestinal form of infection. Viral antigen inside macrophages offers evidence that better fits systemic FIP. Study co-author Benjamin Curtis, DVM, DACVP, a clinical assistant professor with the University of Michigan’s Unit for Laboratory Animal Medicine Pathology Core, says the method pairs cell-level confirmation with less invasive sampling. Effusion fluid or a needle aspirate from affected tissue may be enough, and collection can often take place without general anesthesia.

What the results show—and what they don’t

The clinical trial assessed 84 cats: 58 with FIP and 26 controls diagnosed with other diseases. Researchers compared MF-ICC with RT-PCR, serology and the serum albumin-to-globulin ratio. They determined final case status using necropsy findings with histopathology and immunohistochemistry, response to antiviral treatment, and/or clinical follow-up.

With a positive result defined as at least one cell carrying both markers, MF-ICC had 77 percent sensitivity and 81 percent specificity. Its positive predictive value was 92 percent, its negative predictive value was 53 percent, and its overall accuracy was 78 percent in this group of cats. The albumin-to-globulin ratio had 76 percent accuracy, serology 75 percent and RT-PCR 69 percent.

Evans was struck by how little material could still carry useful information: a single cell positive for both markers gave the best overall accuracy in the analysis. But the results changed with the sample and the form of disease. Testing effusion fluid made MF-ICC more sensitive and less specific. In tissue samples from cats with non-effusive FIP, a positive result carried stronger diagnostic weight—a potentially useful feature when cases are harder to resolve.

The 78 percent accuracy figure does not establish that MF-ICC is categorically better than RT-PCR. The study included a substantial number of cats for veterinary research, but it was too small to settle modest differences between tests. More revealing is that the tests sometimes found different affected cats: MF-ICC detected cases RT-PCR missed, and RT-PCR detected cases MF-ICC missed. Using both may therefore provide a better chance of finding evidence of FIP than relying on either alone.

A positive MF-ICC result can strongly support suspicion, but a negative result cannot reliably rule out FIP. The selected sample, where the disease is active in the body, and the cat’s clinical presentation all shape what a test can detect. For example, in a cat with neurologic or ocular signs, the virus may be concentrated in locations that are difficult to sample.

Diagnosis and treatment decisions

Antiviral treatment has changed the practical consequences of diagnostic uncertainty. A team may need to act quickly for a severely ill cat, while still checking that the evidence supports FIP and considering other causes. Study co-author Benjamin Curtis notes that some cats can deteriorate over days, making a rapid result clinically valuable.

Petra Černá, PhD, DACVIM (SAIM), Dipl. ECVIM-CA, DABVP (Feline), MANZCVS, an assistant professor of small animal internal medicine at the University of Georgia, has encountered cats given antiviral treatment for weeks despite not having FIP. In those situations, treatment may not help the patient and can distract from identifying the condition that does need attention. Fast, accurate testing can support more appropriate decisions.

For general practitioners, MF-ICC may be particularly useful when cytology material is already available, when no sample was retained for RT-PCR, or when PCR is negative but the clinical picture still raises concern for FIP. It adds another source of evidence to the diagnostic process. No single result should carry the whole decision.

Building access and improving the evidence

MF-ICC is a laboratory assay, not an in-clinic test. It requires equipment to concentrate cells onto slides, fluorescent reagents and a pathologist who can interpret the staining. CSU plans to offer the test through its Veterinary Diagnostic Laboratory and assess results as more cases are submitted.

Evans’s group expects the assay to become part of a broader diagnostic service that can combine MF-ICC, PCR, the albumin-to-globulin ratio and other patient information. The group is also developing a machine-learning tool using routine complete blood count and serum biochemistry results. CSU’s FIP biobank and digital repository may support later reviews as more patient outcomes become available.

The method is published and can be established by veterinary diagnostic laboratories with suitable equipment and expertise. Wider availability could shorten the distance samples need to travel and improve turnaround time. The longer-term aim is a minimally invasive test that returns an answer within hours; MF-ICC has not reached that point, but it adds a way to collect evidence from cats before death.

Questions that remain after treatment

Better diagnosis is one part of the work ahead. Černá points to cats that do not improve as expected, particularly severely ill patients with intense systemic inflammation, suspected viral sepsis, immune-mediated hemolytic anemia, myocarditis, coinfections or other concurrent conditions. Research into managing these complications may help improve outcomes for cats that remain difficult to treat.

Longer follow-up will also matter as more cats survive FIP. Černá notes that some recovered cats later develop gastrointestinal disease and that large-cell lymphoma has been reported in some cases. These observations raise questions about health after treatment that were difficult to study when FIP was almost always fatal.

For now, the practical message is to build the diagnosis from the whole patient. Clinical signs, sample choice, MF-ICC, PCR and other findings each contribute a piece of evidence. MF-ICC can make that picture clearer, especially when a positive result fits the cat’s presentation, while a negative finding leaves room for further investigation.

Reference

  1. Evans SJM. The Shifting Paradigm of Feline Infectious Peritonitis: New Diagnostics and Therapeutics. Vet Clin North Am Small Anim Pract. 2026 Jul 30:S0195-5616(26)00082-3. doi: 10.1016/j.cvsm.2026.06.003. Epub ahead of print. PMID: 42532773.
Source: Castillo, Therese · www.veterinarypracticenews.com

Pairs well with